New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
17:22 EDTANTHOrbiMed Advisors reports 6.24% stake in Anthera Pharmaceuticals
News For ANTH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
06:03 EDTANTHAnthera price target raised to $7.50 from $5 at Piper Jaffray
Piper Jaffray raised its price target for shares of Anthera Pharmaceuticals to $7.50 saying the company's strengthened balance sheet is enough to fund its Phase III trials. It reiterates an Overweight rating on the stock.
March 19, 2015
15:02 EDTANTHAnthera gets $3M research award from Cystic Fibrosis Foundation
Anthera Pharmaceuticals announced it has received an award from Cystic Fibrosis Foundation Therapeutic of up to $3M to support the manufacturing and clinical development of Anthera's novel pancreatic enzyme replacement therapy, Sollpura-liprotamase. Cystic Fibrosis Foundation Therapeutics is a non-profit affiliate of the Cystic Fibrosis Foundation.
March 18, 2015
09:23 EDTANTHOn The Fly: Pre-market Movers
Subscribe for More Information
08:45 EDTANTHAnthera Pharmaceuticals 5.5M share Spot Secondary priced at $4.50
Subscribe for More Information
March 17, 2015
19:42 EDTANTHOn The Fly: After Hours Movers
Subscribe for More Information
16:07 EDTANTHAnthera Pharmaceuticals files to sell common stock, no amount given
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use